Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSL1800049	输注用无菌冻干粉Telisotuzumab Vedotin	telisotuzumab vedotin	Lyophilized	Biological Products	Import Drug Application	2018-11-15	AbbVie Inc.	Abbvie Inc	In Review	2018-11-14	view
JXSB2200129	输注用无菌冻干粉Telisotuzumab vedotin	telisotuzumab vedotin	Lyophilized	Biological Products(1)	Supplementary Application	2022-10-15					view
JXSL2200173	输注用无菌冻干粉Telisotuzumab vedotin	telisotuzumab vedotin	Lyophilized	Biological Products(1)	Import Drug Application	2022-09-29					view
JXSB2200118	输注用无菌冻干粉Telisotuzumab vedotin	telisotuzumab vedotin	Lyophilized	Biological Products(1)	Supplementary Application	2022-09-16					view
JXSB2300027	输注用无菌冻干粉Telisotuzumab vedotin	telisotuzumab vedotin	Lyophilized	Biological Products(1)	Supplementary Application	2023-03-11					view
JXSL2200002	输注用无菌冻干粉Telisotuzumab vedotin	telisotuzumab vedotin	Lyophilized	Biological Products(1)	Import Drug Application	2022-01-05					view